LILLY's TAZIDIME (CEFTAZIDIME) LAUNCH SET FOR FIRST WEEK IN DECEMBER FOLLOWING NOV. 20 APPROVAL; REP. WAXMAN SAYS ANTIBIOTICS ARE NOT ELIGIBLE FOR EXCLUSIVITY
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
